Catalog Products » HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Monomer [Biotin], His&Avi, Human
Manual
Manual
COAs

HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Monomer [Biotin], His&Avi, Human

Cancer/testis antigens 83 (CT83), also called KK-LC-1 or CXorf61, recognized by cytotoxic T lymphocytes (CTL), has become a promising target for immunotherapy.
$510.00
Z06813-100

Ask us a question
Product Introduction
Species Human
Protein Construction
HLA-A*01:01&B2M&CT83 (NTDNNLAVY) Monomer [Biotin][ Gly25-Thr305(HLA-A*01:01), Ile21-Met119(B2M) and NTDNNLAVY peptide]
Accession # Q5SUL5(HLA-A*01:01)&P61769(B2M)&NTDNNLAVY		 His Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 50.30 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 55-65 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.
Back

Background
Target Background Cancer/testis antigens 83 (CT83), also called KK-LC-1 or CXorf61, recognized by cytotoxic T lymphocytes (CTL), has become a promising target for immunotherapy.
Synonyms CT83; HLA class I; MHC class I; HLA-A; HLA-A*0101; MHC; MHC HLA-A alpha; NTDNNLAVY
Back

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.